Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report

We treated PR3‐ANCA positive vasculitis in a patient diagnosed with rheumatoid arthritis using rituximab. Monoclonal antibody therapy can be used to simultaneous treat more than one collagen disease in such patients. This suggests that shared pathogenic pathways exist between different collagen dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Akihiro, Sogabe, Ayuko, Okuda, Yasuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752559/
https://www.ncbi.nlm.nih.gov/pubmed/33363811
http://dx.doi.org/10.1002/ccr3.3258
_version_ 1783625890562834432
author Yamada, Akihiro
Sogabe, Ayuko
Okuda, Yasuaki
author_facet Yamada, Akihiro
Sogabe, Ayuko
Okuda, Yasuaki
author_sort Yamada, Akihiro
collection PubMed
description We treated PR3‐ANCA positive vasculitis in a patient diagnosed with rheumatoid arthritis using rituximab. Monoclonal antibody therapy can be used to simultaneous treat more than one collagen disease in such patients. This suggests that shared pathogenic pathways exist between different collagen diseases.
format Online
Article
Text
id pubmed-7752559
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77525592020-12-23 Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report Yamada, Akihiro Sogabe, Ayuko Okuda, Yasuaki Clin Case Rep Case Reports We treated PR3‐ANCA positive vasculitis in a patient diagnosed with rheumatoid arthritis using rituximab. Monoclonal antibody therapy can be used to simultaneous treat more than one collagen disease in such patients. This suggests that shared pathogenic pathways exist between different collagen diseases. John Wiley and Sons Inc. 2020-08-26 /pmc/articles/PMC7752559/ /pubmed/33363811 http://dx.doi.org/10.1002/ccr3.3258 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Yamada, Akihiro
Sogabe, Ayuko
Okuda, Yasuaki
Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report
title Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report
title_full Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report
title_fullStr Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report
title_full_unstemmed Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report
title_short Rituximab used for simultaneous treatment of PR3‐ANCA positive vasculitis associated with rheumatoid arthritis: A case report
title_sort rituximab used for simultaneous treatment of pr3‐anca positive vasculitis associated with rheumatoid arthritis: a case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752559/
https://www.ncbi.nlm.nih.gov/pubmed/33363811
http://dx.doi.org/10.1002/ccr3.3258
work_keys_str_mv AT yamadaakihiro rituximabusedforsimultaneoustreatmentofpr3ancapositivevasculitisassociatedwithrheumatoidarthritisacasereport
AT sogabeayuko rituximabusedforsimultaneoustreatmentofpr3ancapositivevasculitisassociatedwithrheumatoidarthritisacasereport
AT okudayasuaki rituximabusedforsimultaneoustreatmentofpr3ancapositivevasculitisassociatedwithrheumatoidarthritisacasereport

Ejemplares similares